SCHEMBL25523142

SCHEMBL25523142

Cc1ccc(S(=O)(=O)n2cc(I)c3c(N[C@H](C)C(F)(F)F)nc(Cl)nc32)cc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
POLB P06746 1/20 0.32
ALDH3A1 P30838 1/20 0.32
HTT P42858 1/20 0.32
NOD1 Q9Y239 1/20 0.32
YTHDC1 Q96MU7 1/20 0.32
PDE4A P27815 1/20 0.31
PDE4B Q07343 1/20 0.31
PDE4C Q08493 1/20 0.31
PDE4D Q08499 1/20 0.31
HTR6 P50406 2/20 0.31
RAPGEF4 Q8WZA2 1/20 0.31
TDP1 Q9NUW8 2/20 0.30
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30
GAA P10253 1/20 0.30
MAPT P10636 1/20 0.30
HPGD P15428 1/20 0.30
ALOX12 P18054 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30349514 0.87 L3MBTL1 (0.32) ALDH1A1L3MBTL1POLBALDH3A1HTT
SCHEMBL25266043 0.87 L3MBTL1 (0.32) ALDH1A1L3MBTL1POLBALDH3A1HTT
SCHEMBL25201412 0.87 L3MBTL1 (0.32) ALDH1A1L3MBTL1POLBALDH3A1HTT
SCHEMBL1016690 0.83 YTHDC1 (0.41) ALDH1A1L3MBTL1POLBALDH3A1HTT
SCHEMBL1020660 0.79 HDAC1 (0.36) ALDH1A1POLBMEN1KMT2AGAA
SCHEMBL14547756 0.79 RXFP1 (0.38) ALDH1A1L3MBTL1POLBALDH3A1HTT
SCHEMBL1019247 0.79 GPR6 (0.37) ALDH1A1L3MBTL1POLBALDH3A1HTT
SCHEMBL1017371 0.79 ALDH1A1 (0.41) ALDH1A1L3MBTL1POLBALDH3A1HTT
SCHEMBL31052299 0.77 MEN1 (0.42) ALDH1A1L3MBTL1POLBALDH3A1HTT
SCHEMBL1019454 0.77 MAPT (0.46) ALDH1A1L3MBTL1YTHDC1HTR6MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230167133-A1 7H-PYRROLO[2,3-D]PYRIMIDINES AND PREPARATION AND USES THEREOF VICKERS VENTURE FUND VI PTE. LTD. (SG) 2023-06-01 US disclosed
US-20230167133-A1 7H-PYRROLO[2,3-D]PYRIMIDINES AND PREPARATION AND USES THEREOF VICKERS VENTURE FUND VI PTE. LTD. (SG) 2023-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167133-A1 7H-PYRROLO[2,3-D]PYRIMIDINES AND PREPARATION AND USES THEREOF DYRK1A, DYRK1B, DYRK2 ALDH1A1 3447/4885L3MBTL1 2548/4885POLB 185/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.